Market closed

Dr Martens /£DOCS

08:00

10:10

12:15

14:25

16:30

1D1W1MYTD1Y5YMAX

About Dr Martens

Dr. Martens, also known as Docs or DMs, is a United Kingdom-based company renowned for its iconic range of footwear, alongside a variety of clothing and accessories. The company, headquartered in Wollaston, Northamptonshire, operates primarily in the footwear manufacturing sector. Established in 1947, Dr. Martens has grown to become a symbol of self-expression and counterculture, distributing its products worldwide under the Dr. Martens brand.

Ticker

£DOCS

Sector

Consumer Discretionary

Trading on

LSE

Industry

Textiles, Apparel & Luxury Goods

Headquarters

London, United Kingdom

Employees

2,630

Website

www.drmartensplc.com

Dr Martens Metrics

BasicAdvanced

£633M

21.67 £0.03

0.06 £0.03

3.86%

Price and volume

Market cap

£633M

Beta

0.06

52-week high

£1.00

52-week low

£0.49

Average daily volume

2.1M

Dividend rate

£0.03

Financial strength

Current ratio

2.261

Quick ratio

0.976

Long term debt to equity

118.954

Total debt to equity

134.439

Dividend payout ratio (TTM)

51.02%

Interest coverage (TTM)

2.28%

Management effectiveness

Return on assets (TTM)

4.53%

Return on equity (TTM)

8.42%

Valuation

Price to earnings (TTM)

21.667

Price to revenue (TTM)

0.783

Price to book

1.89

Price to tangible book (TTM)

10.4

Price to free cash flow (TTM)

3.1

Dividend yield (TTM)

3.86%

Growth

Revenue change (TTM)

-17.55%

Earnings per share change (TTM)

-70.40%

3-year revenue growth (CAGR)

-0.77%

3-year earnings per share growth (CAGR)

-16.92%

3-year dividend per share growth (CAGR)

14.68%

What the Analysts think about Dr Martens

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for Dr Martens stock.

Dr Martens Financial Performance

Income Statement

Revenues and expenses

QuarterlyAnnual

Q3 24

QoQ growth

Revenue

$37B

-39.75%

Net income

$45B

107.52%

Profit margin

37.65%

6.78%

Dr Martens Earnings Performance

Earnings per share (EPS)

Company profitability

QuarterlyAnnual

Q4 23

Q1 24

Q2 24

Q3 24

Q4 24

Actual

$3.69

$2.85

$2.45

$2.42

-

Expected

$3.55

$2.61

$2.05

$2.31

$3.94

Surprise

3.94%

9.20%

19.51%

4.63%

-

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.

Market data provided by CBOE Europe

Buy £DOCS

£

Capital at risk

Market closed

Upcoming events

Mar6

Dr Martens

Dividend·Ex-dividend

Apr8

Dr Martens

Dividend·Payment

£0.0085

Per share

FAQs

What’s the current market cap for Dr Martens stock?

Dr Martens (DOCS) has a market cap of £633M as of January 15, 2025.

What is the P/E ratio for Dr Martens stock?

The price to earnings (P/E) ratio for Dr Martens (DOCS) stock is 21.67 as of January 15, 2025.

Does Dr Martens stock pay dividends?

Yes, the Dr Martens (DOCS) stock pays dividends to shareholders. As of January 15, 2025, the dividend rate is £0.0255 and the yield is 3.86%. Dr Martens has a payout ratio of 51.02% on a trailing twelve-month basis.

When is the next Dr Martens dividend payment date?

The next Dr Martens (DOCS) dividend payment is scheduled for April 08, 2025.

What is the beta indicator for Dr Martens ?

Dr Martens (DOCS) has a beta rating of 0.06. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.